PASTEUR MERIEUX CONNAUGHT VACCINE SALES GROW 41% IN U.S. DURING 1997; MERCK VACCINES UP 27.5%: COZAAR, CRIXIVAN AND FOSAMAX COMBINE FOR $1 BIL. IN U.S.
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".